{"entity":{"id":"eric-felix-lartigau","kind":"person","name":"Eric Felix Lartigau","aka":[],"tldr":"Eric Felix Lartigau represents Centre Oscar Lambret in the Organisation of European Cancer Institutes, which lists the centre among its members in France.","summary":"Eric Felix Lartigau is listed by the Organisation of European Cancer Institutes (OECI) as the representative of Centre Oscar Lambret, its full member in France. OnCo records the name from the OECI membership list so that the centre's page names its contact within Europe's cancer-centre network; the person's clinical or management role is not stated by the list and should be checked at the institution's website.","asOf":"2026-09-10","links":[{"label":"OECI membership list","url":"https://www.oeci.eu/Membership.aspx"},{"label":"Centre Oscar Lambret website","url":"https://www.centreoscarlambret.fr"}],"tags":["oeci-representative","leader"],"related":["oeci"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["centre-oscar-lambret"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Representative of Centre Oscar Lambret to the Organisation of European Cancer Institutes","institutionId":"centre-oscar-lambret","specialisms":["Cancer centre representation (OECI)"],"profiles":[{"label":"OECI membership list","url":"https://www.oeci.eu/Membership.aspx"},{"label":"Centre Oscar Lambret website","url":"https://www.centreoscarlambret.fr"}],"papers":[{"title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group","journal":"Radiother Oncol","year":2021,"url":"https://doi.org/10.1016/j.radonc.2021.01.013","doi":"10.1016/j.radonc.2021.01.013","note":"Europe PMC author record matched by affiliation"},{"title":"ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer","journal":"Radiother Oncol","year":2017,"url":"https://doi.org/10.1016/j.radonc.2017.05.012","doi":"10.1016/j.radonc.2017.05.012","note":"Europe PMC author record matched by affiliation"},{"title":"Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer","journal":"Radiother Oncol","year":2013,"url":"https://doi.org/10.1016/j.radonc.2013.08.012","doi":"10.1016/j.radonc.2013.08.012","note":"Europe PMC author record matched by affiliation"}]},"route":"/people/eric-felix-lartigau/","neighbours":{"institution":[{"id":"centre-oscar-lambret","kind":"institution","name":"Centre Oscar Lambret","route":"/institutions/centre-oscar-lambret/"},{"id":"oeci","kind":"institution","name":"Organisation of European Cancer Institutes","route":"/institutions/oeci/"}]}}